Predicting blood clots after knee replacement
Part of Blood & lymphatic, Bones, joints & muscles, Heart & circulation clinical trials.
This study looks at whether certain particles in your blood can predict blood clots after knee replacement surgery. By finding these markers, doctors hope to better prevent clots in future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 85 years old.
- This must be your first knee replacement surgery (if the other knee was replaced, it must have been at least 12 months ago).
- You must not be on blood-thinning medication at a full treatment dose.
- You must not have serious health conditions like active infection, kidney failure, or a weakened immune system.
- You must be able to give informed consent and be covered by a social security system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of blood thinners to prevent blood clots after knee replacement surgery. It will help find which one works better and is safer for patients.
This trial compares a personalized approach to preventing blood clots after hip or knee replacement surgery with the standard one-size-fits-all method. The goal is to see if tailoring prevention to each patient works better and is safer.
This study tests a new injection called SRSD107 to see if it prevents blood clots after knee replacement surgery, compared to a standard blood thinner (enoxaparin). It might be an option if you are having a planned knee replacement and are otherwise healthy.
This trial compares a new blood thinner called REGN7508 to two standard blood thinners (apixaban and enoxaparin) to prevent blood clots after total knee replacement surgery. The goal is to see which is safer and more effective.
This trial tests whether an experimental capsule (H001) can prevent dangerous blood clots after knee replacement surgery. It is for people who are scheduled for a first-time total knee replacement and are willing to take the study drug instead of standard blood thinners.
This trial tests a new medicine called REGN7508 against aspirin to prevent blood clots after total knee replacement surgery. It may help if you are having a planned knee replacement and are in good health.
Hear when a new Knee Prosthesis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.